1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow CRC: new trials by email Literature Review of CRC trials Research Report on CRC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies NGM707 plus pembrolizumab - CRC | Phase 2 | Withdrawn | NGM Biopharmaceuticals, Inc | 2023-11-14 | 2026-04-06 |
pembrolizumab (1)